The incongruities of the NPI-Q score obtained by the caregiver versus that obtained directly from the non-demented patient with Parkinson's disease

Revista Ecuatoriana de Neurologia

Volumn 16, Issue 1, 2007, Pages 12-16

  Serrano Dueñas, Marcos ^a,b,c   Serrano, María Soledad ^b  

^a HOSPITAL CARLOS ANDRADE MARÍN   (Ecuador)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DEL ECUADOR   (Ecuador)

^c NONE   (Ecuador)

Author keywords

Consistence inter rater; Convergent validity; Neuropsichiatric inventory short format (NPI Q); Neuropsychiatric symptomatology; Parkinson's disease

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; CAREGIVER; CONSTRUCT VALIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEMENTIA; EVALUATION RESEARCH; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERRATER RELIABILITY; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; POST HOC ANALYSIS; REPRODUCIBILITY; SCORING SYSTEM; SPAIN; TEST RETEST RELIABILITY;

EID: 34250857524     PISSN: 10198113     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Friedman JH, Fernández HH. The non-motor problems of Parkinson's disease. Neurologist 2000;6:18-27.
2. Thanvi BR, Munshi SK, Vijaykumar N, Lo TCN. Neropsychiatric non-motor aspects of Parkinson's disease. Postgrad Med J 2003;79:561-565.
3. Henderson MJ, Mellers JDC. Psychosis in Parkinson's disease: "between a rock and a hard place". International Review of Psychiatry 2000;12:319-334.
4. Ellgring JH. Depression, psychosis, and dementia. Neurology 1999;52(suppl3):S17-S20.
5. Melamed E, Friedberg G, Zoldan J. Psychosis. Impact on the patient and family. Neurology 1999;52(suppl3): S14-S16.
6. Aarsland D, Larsen JP. Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL. Range of neuropsychiatric disturbances in patients with Parkinson's disease J Neurol Neurosurg Psychiatry 1999;67:492-496.
7. Cummings JL, Mega M, Gray K, Rosemberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-2314.
8. Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, López OL, DeKosky ST. Validation of the NPI-Q, a brief clinical form of the Neuropsychiatric Inventory. J Neuropsychiatry Clin Neurosci 2000;12:233-239.
9. Boada M, Cejudo JC, Tárraga L, López OL, Kaufer D.Neuropsychiatric Inventory Questionnaire(NPI-Q): validación española de una forma abreviada del Neuropsychiatric Inventory(NPI). Neurología 2002;17:317-323.
10. Espinás J, Casabella B, Megido MJ, Rico MM. Protocolo de demencias en atención primaria. Formación médica continuada en atención primaria 1999;6(suppl5).
11. Aarslan D, Larsen JP. Diagnosis and treatment of hallucinations and delusions in Parkinson's disease. In: Bédard M-A, Agid Y, Chouinard S, Fahn S, Korczyn AD, Lespérance P, eds. Mental and behavioral dysfunction in movement disorders. Totowa: Humana Press, 2003:369-382.
12. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
13. Tamaño muestral v. 1.1. Unidad de Epidemiología Clínica y Bioestadística. Pontificia Universidad Javeriana. Bogotá - Colombia, 2005.
14. Folstein MF, Folstein SE, Mchugh PR. Mini-Mental State. A practical method for grading the cognitive state of partients for the clinician. J Psychiatry Res 1975;12:189-198.
15. Bermejo F, Gómez TI, Morales JM. El Mini-Mental State Examination en la evaluación del deterioro cognitivo y la demencia. En: del Ser T, Peña-Casanova J, editors. Evaluación neuropsicológica y funcional de la dementia. Barcelona: Prous Science, 1994:93-107.
16. Menza MA, Robertson-Hoffman DE, Bonapace AS. Parkinson's disease and anxiety: Comorbidity with depression. Biol Psychiatry 1993;34:465-470.
17. Nuti A, Ceravolo R, Piccini A, Dell'Agnello G, Bellini G, Gambaccini G, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eu J Neurology 2004;11:315-320.
18. Fahn S, Elton RL, and Members of The UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB, eds. Recent development in Parkinson's disease. New Jersey: McMillan, 1987, Vol 2: 153-163.
19. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967; 17: 427-442.
20. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third Symposium on Parkinson's disease. Edinburgh: E and S Livingstone, 1969; 152-157.
21. Abraira V. El índice kappa. Semergen 2000;27:247-249.
22. Fénelon G, Mahieux F, Huon R, Ziégler M. Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors. Brain 2000;123:733-745.
23. Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry 2005; 76: 58-63.
24. Friedberg G, Zoldan J, Weizman A, Melamed E. Parkinson Psychosis Rating Scale: A practical instrument for grading psychosis in Parkinson's disease. Clin Neuropharmacol 1998;21:280-284.
25. Graham JM, Grunewald RA, Sagar HJ. Hallucinosis in idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;63:434-440.
26. Hobson P, Meara J. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test. Age and Ageing 1999;28:39-43.
27. Marinus J, Visser M, Verwey NA, Verhey FRJ, Middelkopp HAM, Stiggelbout AM, van Hilten JJ. Assessment of cognition in Parkinson's disease. Neurology 2003;61:1222-1228.